Skip to primary navigation
Skip to main content
Skip to primary sidebar

Kahn Swick & Foti

Kahn Swick & Foti represents investors in securities fraud class actions, as well as shareholders and consumers harmed by corporate wrongdoing.

About Us
Attorneys
Practice Areas
Current Cases
KSF News
Client Login

Asset Recovery Services
Contact KSF

No Longer Accepting Claims In This Matter

Home»No Longer Accepting Claims In This Matter

Kahn Swick & Foti, LLC is no longer accepting claims in this matter. Please click here to see our current cases.

Reader Interactions

Primary Sidebar

Current Cases

The Chemours Company (NYSE: CC)

Ruhnn Holding Limited (NasdaqGS: RUHN)

Altria Group, Inc. (NYSE: MO)

SmileDirectClub, Inc. (NasdaqGS: SDC)

Match Group, Inc. (NasdaqGS: MTCH)

Dunkin’ Brands Group, Inc. (NasdaqGS: DNKN) Investigation

KSF News

Lead Plaintiff Defeats Motion to Dismiss in Orexigen Therapeutics Litigation

Lead Plaintiff Defeats Motion to Dismiss in Part in In Re Health Insurance Innovations

KSF Successfully Defended the Ninth Circuit’s Ruling in Orexigen Therapeutics Litigation

Join Our Mailing List

To receive news of interest to shareholders and consumers and learn about potential new cases, you may join our mailing list by entering your email below.

Terms and Conditions | Privacy Notice

Leave this field empty if you're human:

© 2006-2019 Copyright. All rights reserved Kahn Swick & Foti LLC · Louisiana · New York — Kahn Swick & Foti LLP · California